How to set your Pharma or Medtech product up for success in the US market

Pharma Market Access Insights - from Petauri Evidence

Content provided by Petauri Evidence. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Petauri Evidence or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

1+ y ago 43:06

MP3•Episode home

Send us a text

How can you ensure your product is set up for success from early clinical trials right through to launch and commercialisation? In this Global Whispers webinar we explore best practice commercialisation strategy for healthcare products launching in the US market.
Clare Foy (Director – Global Market Access, Mtech Access) speaks to Janice MacLennan (Pharma and Medtech brand strategist and founder of NMBLR) about how market access, HEOR and commercialisation leads in Pharma and Medtech can best support overarching product and brand strategy, with a focus on launch challenges in the US market.
We take a step back from the intricacies of market access and HEOR, to explore the role our specialism plays in broader commercial and product strategy. We ask: where does market access and HEOR sit in this broader picture, and how can market access teams best support their product and company brand?
Using the US market as our case study, we explore:
- How to set up your product for success
- Commercialisation routes in the US for Pharma and Medtech
- The relationship between brand strategy and market access
- What Pharma can learn from Medtech’s approach to commercialisation
- What Medtech innovators can learn from Pharma companies’ approach to launch
This episode was first broadcast as a live webinar in January 2024.
Learn more at: https://mtechaccess.co.uk/commercialisation-strategy-us-market/
Explore our work in the US market: https://mtechaccess.co.uk/launching-healthcare-products-in-the-us/
Discover how Mtech Access can support you global market access and pricing strategy: https://mtechaccess.co.uk/global-market-access-and-pricing/

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Chapters

1. Introductions and welcome (00:00:00)

2. Challenges of launching a Pharma or Medtech product in the USA (00:02:30)

3. Changes in the US healthcare market (00:05:47)

4. Key early decisions when preparing to launch (00:08:24)

5. Collaborating with other internal stakeholders and teams (00:13:05)

6. What can you do to future proof your product? (00:18:40)

7. Accelerating the pre-launch timeline (00:22:19)

8. Generating the right evidence for launch (00:25:49)

9. Patient access for the insured and un-insured in the US (00:28:42)

10. Post-launch strategies for Pharma and Medtech in the US (00:32:45)

11. What are the main pitfalls in the US market and how to avoid these? (00:35:43)

12. What lessons would you share with Pharma and Medtech companies? (00:39:49)

69 episodes

#Science #Fitness #Biology #Business #Medicine #Mtech Access #Pharmaceutical #Pharma #Market Access #Health Economics #Heores #Medtech #NHS #Healthcare